- Home
- NB vs RLMD Comparison
NB vs RLMD Comparison
Compare NB & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NB | RLMD |
|---|---|---|
| Founded | 1987 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.0M | 461.9M |
| IPO Year | 2016 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NB | RLMD |
|---|---|---|
| Price | $4.10 | $4.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $6.93 | ★ $12.40 |
| AVG Volume (30 Days) | ★ 3.3M | 1.1M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.28 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 154.83 |
| 52 Week Low | $3.82 | $1.30 |
| 52 Week High | $12.58 | $8.00 |
Technical Indicators
Market Signals| Indicator | NB | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 34.38 |
| Support Level | $3.82 | $4.29 |
| Resistance Level | $4.99 | $4.48 |
| Average True Range (ATR) | 0.25 | 0.18 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 11.97 | 14.39 |
Price Performance
Historical ComparisonAbout NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.